P-A-W Capital Corp decreased its stake in Chemocentryx Inc (CCXI) by 44.44% based on its latest 2018Q4 regulatory filing with the SEC. P-A-W Capital Corp sold 40,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 50,000 shares of the health care company at the end of 2018Q4, valued at $546,000, down from 90,000 at the end of the previous reported quarter. P-A-W Capital Corp who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $693.09 million market cap company. The stock decreased 0.33% or $0.04 during the last trading session, reaching $11.94. About 281,905 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 15, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19
Nine Masts Capital Ltd decreased its stake in Baidu Inc (BIDU) by 39.51% based on its latest 2018Q4 regulatory filing with the SEC. Nine Masts Capital Ltd sold 3,462 shares as the company’s stock declined 14.60% while stock markets rallied. The hedge fund held 5,300 shares of the technology company at the end of 2018Q4, valued at $841,000, down from 8,762 at the end of the previous reported quarter. Nine Masts Capital Ltd who had been investing in Baidu Inc for a number of months, seems to be less bullish one the $53.24 billion market cap company. The stock increased 0.56% or $0.85 during the last trading session, reaching $152.39. About 3.28M shares traded or 0.92% up from the average. Baidu, Inc. (NASDAQ:BIDU) has declined 35.57% since May 15, 2018 and is downtrending. It has underperformed by 39.94% the S&P500. Some Historical BIDU News: 08/05/2018 – Baidu to integrate Nuomi Pictures with iQiyi soon, sources say; 26/04/2018 – BAIDU – RMB 41.2 BLN RELATED WITH CO’S FINANCIAL SERVICE BUSINESS WERE RECLASSIFIED TO ASSETS, LIABILITIES HELD FOR SALE ON BALANCE SHEET AS OF MARCH 31; 16/03/2018 – SKYWORTHDIGITAL SAYS INVESTOR IS A SUBSIDIARY OF BAIDU; 18/05/2018 – Ql LU TO TRANSITION INTO NEW ROLE AT BAIDU, BAIDU PROMOTES HAIFENG WANG TO SENIOR VICE PRESIDENT; 27/04/2018 – Baidu said it now expects second-quarter revenues of between 24.91 billion yuan ($3.93 billion) and 26.19 billion yuan ($4.13 billion), indicating a 19.3-25.4 percent rise versus estimates of a 15.9 percent climb according to Thomson Reuters; 18/05/2018 – Baidu’s COO steps down less than 2 years after joining; 21/05/2018 – After Divestiture, Baidu No Longer Will Have Effective Control of Global DU Business; 20/05/2018 – Baidu Has Biggest Loss Since October; Chinese ADRs Friday; 20/03/2018 – Computershare’s new “tailor made” Asian share plan platform helps Baidu increase usage four-fold; 18/05/2018 – BAIDU PROMOTES HAIFENG WANG TO SVP
Analysts await Baidu, Inc. (NASDAQ:BIDU) to report earnings on May, 16 after the close. They expect $-0.10 earnings per share, down 104.44% or $2.35 from last year’s $2.25 per share. After $1.32 actual earnings per share reported by Baidu, Inc. for the previous quarter, Wall Street now forecasts -107.58% negative EPS growth.
More notable recent Baidu, Inc. (NASDAQ:BIDU) news were published by: Nasdaq.com which released: “Will Alibaba Stock Rally on Rival Amazonâ€™s Partial Exit From China? – Nasdaq” on April 23, 2019, also Nasdaq.com with their article: “Baidu Brings Multiple Connected Vehicle Solutions and Enterprise Applications with 14 partners to Auto Shanghai 2019 – Nasdaq” published on April 18, 2019, Forbes.com published: “What To Watch For In Baidu’s Q1 Earnings – Forbes” on May 14, 2019. More interesting news about Baidu, Inc. (NASDAQ:BIDU) were released by: Nasdaq.com and their article: “Baidu (BIDU) 1st Quarter Earnings: What to Expect – Nasdaq” published on April 22, 2019 as well as Seekingalpha.com‘s news article titled: “Buy Baidu Ahead Of China Nasdaq Board Launch – Seeking Alpha” with publication date: April 05, 2019.
Nine Masts Capital Ltd, which manages about $517.59M US Long portfolio, upped its stake in Fluor Corp New (NYSE:FLR) by 56,421 shares to 56,742 shares, valued at $1.83M in 2018Q4, according to the filing. It also increased its holding in Sysco Corp (NYSE:SYY) by 47,592 shares in the quarter, for a total of 48,092 shares, and has risen its stake in Advanced Micro Devices Inc (Call) (NASDAQ:AMD).
Since January 7, 2019, it had 0 buys, and 5 selling transactions for $1.38 million activity. 36,762 shares valued at $447,092 were sold by Schall Thomas J. on Thursday, January 10. The insider Cappel Markus J. sold 13,203 shares worth $158,790.
Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It turned negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Macquarie Limited has invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Moreover, Barclays Pcl has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 5,866 shares. Fmr Ltd Liability Corp owns 644,305 shares. Smith Asset Mgmt Group Lp stated it has 22,897 shares. Fernwood Invest Ltd Liability holds 10,000 shares or 0.07% of its portfolio. Vanguard Grp Inc Inc, Pennsylvania-based fund reported 1.36M shares. Moreover, Panagora Asset Management has 0.02% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 324,223 shares. State Bank Of Montreal Can reported 129,083 shares or 0% of all its holdings. Daiwa Group Incorporated holds 0% or 269 shares. The Switzerland-based Swiss Comml Bank has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Meeder Asset Management accumulated 0% or 3,035 shares. Ameritas Inv Ptnrs Inc holds 2,120 shares or 0% of its portfolio. Rhumbline Advisers has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). 1,170 were reported by Dorsey Wright Associates. Farallon Cap Ltd Liability Corp reported 0.13% stake.
P-A-W Capital Corp, which manages about $79.74M US Long portfolio, upped its stake in Usa Technologies Inc (NASDAQ:USAT) by 170,945 shares to 180,000 shares, valued at $700,000 in 2018Q4, according to the filing.
Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on August, 8. They expect $-0.26 earnings per share, down 85.71% or $0.12 from last year’s $-0.14 per share. After $-0.23 actual earnings per share reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 13.04% negative EPS growth.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.